| Mark C Sivakoff, MD | |
|
15351 W Bell Rd, Surprise, AZ 85374-4580 | |
| (877) 809-5092 | |
| (623) 815-9253 |
| Full Name | Mark C Sivakoff |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 15351 W Bell Rd, Surprise, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063416758 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 34095 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark C Sivakoff, MD 9520 W Palm Ln, Suite 200, Phoenix, AZ 85037-4403 Ph: (877) 809-5092 | Mark C Sivakoff, MD 15351 W Bell Rd, Surprise, AZ 85374-4580 Ph: (877) 809-5092 |
News Archive
A team of University of Pittsburgh, Michigan Medicine, Medical University of South Carolina and Stanford Medicine. researchers recently were awarded funds from the National Heart, Lung, and Blood Institute in collaboration with the Biomedical Advanced Research and Development Authority, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, totaling more than $7 million to collaboratively study the role of convalescent plasma in mitigating symptoms of COVID-19 in patients with mild illness and preventing the progression of the disease from mild to severe.
One hidden cost of obesity is lost productivity in the workplace a problem with a price tag as high as $73.1 billion, according to a new study, Agence France-Presse reports.
Risk of suicide after self-harm; work stress in non-consultant hospital doctors; and monitoring and assessing the impact of the economic crisis on the Irish health system are among the research areas that will be explored by scholars of an innovative new PhD programme in population health and health services research.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New Drug Application (NDA) submission for BYDUREON™ (exenatide for extended-release injectable suspension).
› Verified 2 days ago
Dr. Paulina Elise Mariki-mhango, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 15351 W Bell Rd, Surprise, AZ 85374 Phone: 623-583-3001 | |
Dr. Mark J Pyle, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 15351 W Bell Rd, Surprise, AZ 85374 Phone: 480-964-2273 Fax: 623-214-5214 | |
Daryl R Marcelo, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 14239 W Bell Rd, Suite 112, Surprise, AZ 85374 Phone: 623-876-9983 Fax: 623-876-9984 | |
Mrs. Tinuola K Babarinde, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 14741 W Mountain View Blvd Ste 149, Surprise, AZ 85374 Phone: 623-975-5400 Fax: 623-975-6004 | |
Angela Johansson, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 15351 W Bell Rd, Surprise, AZ 85374 Phone: 877-809-5092 Fax: 623-214-5231 | |
Dr. Brian Lawrence Young, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 15653 N Reems Rd, Suite 110, Surprise, AZ 85374 Phone: 623-214-3454 Fax: 623-214-3455 |